iMediSync

Who is iMediSync? - iMediSync Inc is a AI-driven early detection therapeutic platform for optimal brain health. - iMediSync originated from National Standard Data Center for Korean EEG, Seoul National University which has developed Asia’s first QEEG normative DB with more than 1300 healthy subjects ranging from 4 – 90 years old. - iSyncBrain® (https://isyncbrain.com) is an AI driven analysis cloud platform. It has been registered as a class II medical device by the Korean FDA, and users from more than 30 countries are using the platform. - Our early detection EEG algorithm for aMCI, “iSyncBrain – MCI Classifier” was developed and clinically validated with three Korean university hospitals (sensitivity, specificity >90%). It also got the clearance from Korean FDA as a class II medical device for (different underlying pathology) - iSyncHeart® is an AI cloud-based solution for heart rate variability (HRV). It was launched and has been registered as a class II medical device by the Korean FDA. It has been used for remote ECG monitoring of participants in clinical trials. - iSyncBrain® and iSyncHeart® platform are primarily used by doctors and clinical psychologists for research purposes. And it will be expanded for virtual telemental care by June 2021. - The vision of iMediSync is to develop early detecting biomarkers for challenging neurological disorders such as Parkinson’s disease, TBI, PTSD, ADHD, and Depression.